Conditions & Recovery · NCI News Releases · February 13, 2025

Gene therapy shows clinical benefit in patients with a debilitating disorder caused by HPV

An NCI clinical trial showed that an experimental gene therapy called PRGN-2012 may be an effective treatment for recurrent respiratory papillomatosis, which is caused by HPV 6 and HPV 11.

Originally published by NCI News Releases. We curate and add context; they did the reporting.

Read the full story at NCI News Releases ↗

Related learning

Biotech Firm Claims Some Credit for Groundbreaking Virus Research Biotech Firm Claims Some Credit for Groundbreaking Virus Research James P. Allison, Ph.D., bangs gong after completing proton therapy treatment Combination therapy helps plasmacytoid bladder cancer survivor